Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share Stock Price, News & Analysis (NASDAQ:AVDL)

$8.74 -0.12 (-1.35 %)
(As of 12/13/2017 04:00 PM ET)
Previous Close$8.86
Today's Range$8.71 - $8.95
52-Week Range$7.52 - $12.30
Volume77,890 shs
Average Volume185,733 shs
Market Capitalization$358.75 million
P/E Ratio16.57
Dividend YieldN/A
Beta1.34

About Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share logoAvadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to commercialize differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.

Receive AVDL News and Ratings via Email

Sign-up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Delivery
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AVDL
CUSIPN/A
Phone011-1-485-1200

Debt

Debt-to-Equity Ratio0.01%
Current Ratio1.53%
Quick Ratio1.47%

Price-To-Earnings

Trailing P/E Ratio16.57
Forward P/E Ratio31.21
P/E GrowthN/A

Sales & Book Value

Annual Sales$150.25 million
Price / Sales2.33
Cash Flow$0.28 per share
Price / Cash31.14
Book Value$1.02 per share
Price / Book8.57

Profitability

Trailing EPS$1.90
Net Income$-41,270,000.00
Net Margins44.47%
Return on Equity33.92%
Return on Assets8.94%

Miscellaneous

Employees192
Outstanding Shares40,080,000

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Frequently Asked Questions

What is Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock symbol?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share trades on the NASDAQ under the ticker symbol "AVDL."

How were Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's earnings last quarter?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) issued its quarterly earnings results on Wednesday, November, 8th. The company reported $0.09 EPS for the quarter, beating the Zacks' consensus estimate of ($0.04) by $0.13. The company earned $39.68 million during the quarter, compared to the consensus estimate of $38.22 million. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share had a return on equity of 33.92% and a net margin of 44.47%. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's revenue was up 23.7% on a year-over-year basis. During the same period last year, the business posted ($0.08) earnings per share. View Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's Earnings History.

When will Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share make its next earnings announcement?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share is scheduled to release their next quarterly earnings announcement on Tuesday, March, 6th 2018. View Earnings Estimates for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share.

What guidance has Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share issued on next quarter's earnings?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share issued an update on its FY17 earnings guidance on Wednesday, November, 8th. The company provided earnings per share (EPS) guidance of $0.25-0.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.35. The company issued revenue guidance of $165-175 million, compared to the consensus revenue estimate of $170.67 million.

Where is Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock going? Where will Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock price be in 2017?

2 analysts have issued 1-year target prices for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock. Their forecasts range from $15.00 to $30.00. On average, they expect Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's share price to reach $25.00 in the next twelve months. View Analyst Ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share.

Who are some of Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's key competitors?

Who owns Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Janus Henderson Group PLC (5.37%), Perceptive Advisors LLC (3.86%), Stonepine Capital Management LLC (2.46%), Russell Investments Group Ltd. (1.12%), OxFORD Asset Management LLP (0.72%) and Ameriprise Financial Inc. (0.51%). Company insiders that own Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock include Craig R Stapleton, Francis Fildes, Greg J Divis, Guillaume Cerutti, Healthcare Master Fun Broadfin, Michael S Anderson, Peter J Thornton, Phillandas T Thompson and Sandra L Hatten. View Institutional Ownership Trends for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share.

Who sold Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock? Who is selling Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock was sold by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, OxFORD Asset Management LLP, JPMorgan Chase & Co., Janus Henderson Group PLC, Columbus Circle Investors and Russell Investments Group Ltd.. Company insiders that have sold Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share company stock in the last year include Craig R Stapleton, Guillaume Cerutti and Healthcare Master Fun Broadfin. View Insider Buying and Selling for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share.

Who bought Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock? Who is buying Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock was acquired by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Janney Montgomery Scott LLC, Boston Partners, Perceptive Advisors LLC, Dynamic Technology Lab Private Ltd, Ameriprise Financial Inc., Cubist Systematic Strategies LLC and Nine Chapters Capital Management LLC. Company insiders that have bought Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock in the last two years include Craig R Stapleton, Greg J Divis, Michael S Anderson, Peter J Thornton, Phillandas T Thompson and Sandra L Hatten. View Insider Buying and Selling for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share.

How do I buy Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock?

Shares of Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's stock price today?

One share of Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share stock can currently be purchased for approximately $8.74.

How big of a company is Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share has a market capitalization of $358.75 million and generates $150.25 million in revenue each year. The company earns $-41,270,000.00 in net income (profit) each year or $1.90 on an earnings per share basis. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share employs 192 workers across the globe.

How can I contact Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share?

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share's mailing address is Block 10-1 Blanchardstown Corporate ParkBallycoolin, Dublin L2, 69693. The company can be reached via phone at 011-1-485-1200 or via email at [email protected]


MarketBeat Community Rating for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  152 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  243
MarketBeat's community ratings are surveys of what our community members think about Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.40$21.40$21.40$18.63
Price Target Upside: 138.84% upside138.84% upside138.84% upside43.27% upside

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Consensus Price Target History

Price Target History for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/7/2017Langenberg & CompanyReiterated RatingBuy$27.00 -> $30.00LowView Rating Details
9/7/2017Ladenburg Thalmann Financial ServicesBoost Price Target$27.00 -> $30.00LowView Rating Details
8/9/2017Roth CapitalSet Price TargetBuy$15.00LowView Rating Details
9/28/2016JMP SecuritiesReiterated RatingOutperform$16.00N/AView Rating Details
9/27/2016Leerink SwannReiterated RatingOutperform$16.00N/AView Rating Details
1/21/2016LaidlawLower Price TargetBuy$30.00 -> $25.00N/AView Rating Details
1/4/2016SunTrust BanksReiterated RatingBuyN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Earnings History and Estimates Chart

Earnings by Quarter for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ AVDL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2018        
11/8/2017Q3($0.04)$0.09$38.22 million$39.68 millionViewN/AView Earnings Details
8/8/20176/30/2017$0.05$0.19$45.17 million$46.30 millionViewListenView Earnings Details
5/9/20173/31/2017$0.07$0.26$46.01 million$52.50 millionViewListenView Earnings Details
3/7/201712/31/2016($0.03)$0.26$34.72 million$43.09 millionViewListenView Earnings Details
11/7/2016Q316($0.07)($0.08)$30.70 million$32.10 millionViewListenView Earnings Details
8/8/2016Q216$0.06($0.02)$32.80 million$38.90 millionViewN/AView Earnings Details
5/9/2016Q116$0.14$0.04$34.00 million$36.20 millionViewN/AView Earnings Details
3/10/2016Q415$0.09$0.32$44.69 million$43.40 millionViewListenView Earnings Details
11/12/2015Q215$0.23$0.28$50.33 million$47.30 millionViewListenView Earnings Details
7/30/2015Q2$0.40$0.34$62.50 million$49.80 millionViewListenView Earnings Details
5/15/2015Q115$0.18$0.34$37.37 million$32.73 millionViewListenView Earnings Details
3/19/2015Q414($0.22)($0.12)$13.10 million$3.00 millionViewN/AView Earnings Details
10/31/2014Q3 14($0.12)($0.16)$12.00 million$7.00 millionViewN/AView Earnings Details
7/29/2014Q214($0.08)($0.13)$9.92 million$8.10 millionViewN/AView Earnings Details
5/12/2014Q1 14($0.15)($0.15)$7.47 million$9.20 millionViewN/AView Earnings Details
10/31/2013Q313($0.20)($0.25)$6.47 million$5.60 millionViewN/AView Earnings Details
7/29/2013Q2 2013($0.27)($0.09)$5.35 million$5.50 millionViewN/AView Earnings Details
5/7/2013Q1 2013($0.33)($0.23)$6.11 million$5.10 millionViewN/AView Earnings Details
11/5/2012Q312($0.19)($0.26)$6.35 million$5.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Earnings Estimates

2017 EPS Consensus Estimate: $0.15
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.06$0.07$0.07
Q2 20173$0.04$0.08$0.06
Q3 20173($0.02)$0.07$0.03
Q4 20173($0.15)$0.07($0.01)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ AVDL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.07%
Institutional Ownership Percentage: 67.81%
Insider Trades by Quarter for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)
Institutional Ownership by Quarter for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ AVDL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/7/2017Michael S. AndersonCEOBuy5,000$8.86$44,300.00View SEC Filing  
11/27/2017Craig R StapletonDirectorSell254,265$9.35$2,377,377.75View SEC Filing  
9/21/2017Peter J ThorntonDirectorBuy5,155$9.74$50,209.70View SEC Filing  
9/14/2017Sandra L. HattenInsiderBuy2,100$9.36$19,656.00View SEC Filing  
9/13/2017Phillandas T. ThompsonInsiderBuy5,000$9.36$46,800.00View SEC Filing  
9/12/2017Craig R StapletonDirectorBuy20,000$9.52$190,400.00View SEC Filing  
9/12/2017Greg J DivisInsiderBuy10,600$9.32$98,792.00View SEC Filing  
9/12/2017Michael S. AndersonCEOBuy4,000$9.80$39,200.00View SEC Filing  
6/23/2017Healthcare Master Fun BroadfinMajor ShareholderSell261,000$10.68$2,787,480.00View SEC Filing  
6/15/2017Guillaume CeruttiDirectorSell26,560$10.46$277,817.60View SEC Filing  
5/22/2017Craig R StapletonDirectorBuy31,013$9.85$305,478.05View SEC Filing  
5/19/2017Michael S AndersonCEOBuy2,500$10.00$25,000.00View SEC Filing  
11/29/2016Craig R StapletonDirectorBuy20,000$10.79$215,800.00View SEC Filing  
11/21/2016Michael S. AndersonCEOBuy2,000$10.64$21,280.00View SEC Filing  
9/22/2016Francis FildesDirectorSell15,000$13.45$201,750.00View SEC Filing  
9/2/2016Michael S. AndersonCEOBuy2,000$14.12$28,240.00View SEC Filing  
9/1/2016Craig R StapletonDirectorBuy10,000$13.52$135,200.00View SEC Filing  
8/26/2016Craig R StapletonDirectorBuy20,000$13.76$275,200.00View SEC Filing  
8/22/2016Michael S. AndersonCEOBuy5,000$14.30$71,500.00View SEC Filing  
5/16/2016Craig R StapletonDirectorBuy27,228$9.21$250,769.88View SEC Filing  
5/12/2016Michael S AndersonCEOBuy5,000$8.84$44,200.00View SEC Filing  
3/22/2016Phillandas T ThompsonInsiderBuy10,000$11.10$111,000.00View SEC Filing  
3/18/2016Michael S AndersonCEOBuy5,000$11.04$55,200.00View SEC Filing  
3/18/2016Sandra L HattenVPBuy3,000$11.01$33,030.00View SEC Filing  
3/14/2016Craig R StapletonDirectorBuy100,000$10.39$1,039,000.00View SEC Filing  
3/14/2016Michael S AndersonInsiderBuy10,000$9.74$97,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ AVDL) News Headlines

Source:
DateHeadline
Head-To-Head Contrast: Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Head-To-Head Contrast: Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 12 at 3:24 AM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) CEO Buys $44,300.00 in StockAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) CEO Buys $44,300.00 in Stock
www.americanbankingnews.com - December 11 at 6:00 PM
Should You Expect Avadel Pharmaceuticals plc (AVDL) To Continue Delivering An ROE Of 121.91%?Should You Expect Avadel Pharmaceuticals plc (AVDL) To Continue Delivering An ROE Of 121.91%?
finance.yahoo.com - December 11 at 11:22 AM
Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Financial ContrastAcura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Financial Contrast
www.americanbankingnews.com - December 11 at 5:38 AM
Head-To-Head Contrast: Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Head-To-Head Contrast: Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 10 at 1:36 PM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR) Financial SurveyAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR) Financial Survey
www.americanbankingnews.com - December 10 at 3:26 AM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Upgraded to Sell by BidaskClubAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Upgraded to Sell by BidaskClub
www.americanbankingnews.com - December 9 at 10:36 AM
Financial Analysis: Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Financial Analysis: Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 8 at 3:30 PM
$30.01 Million in Sales Expected for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) This Quarter$30.01 Million in Sales Expected for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) This Quarter
www.americanbankingnews.com - December 8 at 8:28 AM
Financial Comparison: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)Financial Comparison: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 6 at 2:48 PM
Head to Head Analysis: Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Head to Head Analysis: Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 5 at 1:26 PM
Financial Analysis: Acura Pharmaceuticals (ACUR) versus Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Financial Analysis: Acura Pharmaceuticals (ACUR) versus Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 1 at 5:12 PM
Head-To-Head Analysis: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Head-To-Head Analysis: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 1 at 2:24 PM
Contrasting Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Contrasting Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - November 30 at 11:18 AM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Director Craig R. Stapleton Sells 254,265 SharesAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Director Craig R. Stapleton Sells 254,265 Shares
www.americanbankingnews.com - November 29 at 7:26 PM
Contrasting Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Contrasting Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 29 at 3:30 AM
Avadel Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare ConferenceAvadel Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 27 at 3:31 PM
Contrasting Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals PLC. (AVDL)Contrasting Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals PLC. (AVDL)
www.americanbankingnews.com - November 22 at 4:02 PM
Avadel Pharmaceuticals PLC. (AVDL) and Acura Pharmaceuticals (ACUR) Head-To-Head ReviewAvadel Pharmaceuticals PLC. (AVDL) and Acura Pharmaceuticals (ACUR) Head-To-Head Review
www.americanbankingnews.com - November 21 at 9:24 PM
Avadel Pharmaceuticals PLC. (AVDL) Expected to Post Quarterly Sales of $30.01 MillionAvadel Pharmaceuticals PLC. (AVDL) Expected to Post Quarterly Sales of $30.01 Million
www.americanbankingnews.com - November 20 at 9:04 AM
Head to Head Comparison: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)Head to Head Comparison: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 20 at 3:08 AM
Comparing Avadel Pharmaceuticals PLC. (AVDL) and Acura Pharmaceuticals (ACUR)Comparing Avadel Pharmaceuticals PLC. (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 19 at 9:28 PM
Financial Review: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)Financial Review: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 19 at 11:36 AM
Head to Head Contrast: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)Head to Head Contrast: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 19 at 5:22 AM
 Brokerages Anticipate Avadel Pharmaceuticals PLC. (AVDL) to Post -$0.29 Earnings Per Share Brokerages Anticipate Avadel Pharmaceuticals PLC. (AVDL) to Post -$0.29 Earnings Per Share
www.americanbankingnews.com - November 18 at 5:18 PM
Avadel Pharmaceuticals PLC. (AVDL) vs. Acura Pharmaceuticals (ACUR) Financial SurveyAvadel Pharmaceuticals PLC. (AVDL) vs. Acura Pharmaceuticals (ACUR) Financial Survey
www.americanbankingnews.com - November 17 at 2:42 PM
Head-To-Head Analysis: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)Head-To-Head Analysis: Avadel Pharmaceuticals PLC. (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 17 at 7:22 AM
Head-To-Head Survey: Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals PLC. (AVDL)Head-To-Head Survey: Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals PLC. (AVDL)
www.americanbankingnews.com - November 16 at 10:18 AM
Avadel Pharmaceuticals PLC. (AVDL) Lifted to "Hold" at Zacks Investment ResearchAvadel Pharmaceuticals PLC. (AVDL) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - November 14 at 7:56 PM
Featured Company News - Alkermes Presents Positive Pre-Clinical Data On Immuno-Oncology Drug Candidate ALKS 4230Featured Company News - Alkermes Presents Positive Pre-Clinical Data On Immuno-Oncology Drug Candidate ALKS 4230
finance.yahoo.com - November 10 at 1:27 PM
Avadel Pharmaceuticals (AVDL) CEO Michael Anderson on Q3 2017 Results - Earnings Call TranscriptAvadel Pharmaceuticals' (AVDL) CEO Michael Anderson on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 6:32 PM
Avadel Pharmaceuticals Reports Third Quarter 2017 ResultsAvadel Pharmaceuticals Reports Third Quarter 2017 Results
finance.yahoo.com - November 8 at 6:32 PM
Avadel posts 3Q profitAvadel posts 3Q profit
finance.yahoo.com - November 8 at 6:32 PM
Avadel Pharmaceuticals PLC. (AVDL) Posts Quarterly  Earnings Results, Beats Estimates By $0.10 EPSAvadel Pharmaceuticals PLC. (AVDL) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS
www.americanbankingnews.com - November 8 at 2:42 PM
Avadel Pharmaceuticals PLC. (AVDL) Issues FY17 Earnings GuidanceAvadel Pharmaceuticals PLC. (AVDL) Issues FY17 Earnings Guidance
www.americanbankingnews.com - November 8 at 10:39 AM
Avadel Pharmaceuticals to Host Analyst and Investor Meeting - GlobeNewswire (press release)Avadel Pharmaceuticals to Host Analyst and Investor Meeting - GlobeNewswire (press release)
globenewswire.com - November 7 at 3:17 AM
Avadel Pharmaceuticals to Host Analyst and Investor MeetingAvadel Pharmaceuticals to Host Analyst and Investor Meeting
finance.yahoo.com - November 6 at 5:11 PM
Avadel Pharmaceuticals to Host Analyst and Investor MeetingAvadel Pharmaceuticals to Host Analyst and Investor Meeting
finance.yahoo.com - November 6 at 5:11 PM
Avadel Pharmaceuticals PLC. (AVDL) to Release Earnings on WednesdayAvadel Pharmaceuticals PLC. (AVDL) to Release Earnings on Wednesday
www.americanbankingnews.com - November 1 at 8:32 AM
$36.80 Million in Sales Expected for Avadel Pharmaceuticals PLC. (AVDL) This Quarter$36.80 Million in Sales Expected for Avadel Pharmaceuticals PLC. (AVDL) This Quarter
www.americanbankingnews.com - October 31 at 9:10 AM
Avadel Pharmaceuticals: Dont Sleep On This Company, Just Its ProductsAvadel Pharmaceuticals: Don't Sleep On This Company, Just Its Products
seekingalpha.com - October 26 at 4:13 PM
Avadel Pharmaceuticals to Report Third Quarter 2017 ResultsAvadel Pharmaceuticals to Report Third Quarter 2017 Results
finance.yahoo.com - October 20 at 6:00 PM
What does Avadel Pharmaceuticals plc’s (AVDL) Balance Sheet Tell Us Abouts Its Future?What does Avadel Pharmaceuticals plc’s (AVDL) Balance Sheet Tell Us Abouts Its Future?
finance.yahoo.com - October 19 at 9:48 PM
Zacks Investment Research Lowers Avadel Pharmaceuticals PLC. (AVDL) to SellZacks Investment Research Lowers Avadel Pharmaceuticals PLC. (AVDL) to Sell
www.americanbankingnews.com - October 16 at 8:10 PM
SunTrust Banks Equities Analysts Decrease Earnings Estimates for Avadel Pharmaceuticals PLC. (AVDL)SunTrust Banks Equities Analysts Decrease Earnings Estimates for Avadel Pharmaceuticals PLC. (AVDL)
www.americanbankingnews.com - October 16 at 7:56 AM
 Brokerages Expect Avadel Pharmaceuticals PLC. (AVDL) to Announce $0.01 Earnings Per Share Brokerages Expect Avadel Pharmaceuticals PLC. (AVDL) to Announce $0.01 Earnings Per Share
www.americanbankingnews.com - October 10 at 12:18 AM
Avadel Pharmaceuticals Announces Data Presentation for Noctiva™ at The American Urogynecologic Societys Annual ... - GlobeNewswire (press release)Avadel Pharmaceuticals Announces Data Presentation for Noctiva™ at The American Urogynecologic Society's Annual ... - GlobeNewswire (press release)
globenewswire.com - October 5 at 2:08 PM
Avadel Pharmaceuticals Announces Data Presentation for Noctiva™ at The American Urogynecologic Society’s Annual Scientific MeetingAvadel Pharmaceuticals Announces Data Presentation for Noctiva™ at The American Urogynecologic Society’s Annual Scientific Meeting
finance.yahoo.com - October 5 at 2:08 PM
At $10.73, Is Avadel Pharmaceuticals plc (AVDL) A Buy?At $10.73, Is Avadel Pharmaceuticals plc (AVDL) A Buy?
finance.yahoo.com - October 3 at 3:55 PM
Flamel Technologies S.A. (AVDL) Director Acquires $50,209.70 in StockFlamel Technologies S.A. (AVDL) Director Acquires $50,209.70 in Stock
www.americanbankingnews.com - September 25 at 7:36 PM

SEC Filings

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ AVDL) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.